About Serbia Molecules
Serbia Molecules is a Healthcare company based in Karnal (India) founded in 2012. A pharmaceutical marketing and PCD company offering products to distributors and franchise partners. It operates on a B2B model. Its Indian entity Serbia Molecules Private Limited reported revenue of ₹50.8 Lakh. Its focus areas include Pharmaceuticals, Marketing and Distribution and Product Formulations. Its competitors include Sayre Therapeutics, Ethosh and An Pharma; 2 of its 3 listed competitors have raised funding.
Company details
Serbia Molecules operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, marketing and distribution, and product formulations. A pharmaceutical marketing and PCD company offering products to distributors and franchise partners. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Karnal, India
- SectorsHealthcare
- Website serbiamolecules.in/cgi-sys/suspendedpage.cgi
- Social Facebook
- Legal Name Serbia Molecules Private Limited
- Date of Incorporation 25 Jun, 2012
- Jurisdiction Karnal, Haryana, India
- Annual Revenue₹50.8 Lakh
FY 2025 · -74% YoY
- Net Loss-₹53,124
FY 2025 · -1% margin
- EBITDA₹1.2 Lakh
FY 2025 · 2% margin
Associated legal entities of Serbia Molecules
Serbia Molecules operates through Serbia Molecules Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Serbia Molecules Private Limited CIN U85100HR2012PTC046341 | Active | 25 Jun 2012 | Karnal, Haryana | ₹0.5 Cr | 4 | View details |
Board of directors of Serbia Molecules Private Limited (Serbia Molecules)
Serbia Molecules Private Limited is the primary company behind Serbia Molecules. The board of Serbia Molecules Private Limited currently have 4 directors; the longest-serving is Anil Kumar, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Kumar DIN 05298681 | Director | 25 Jun 2012 | 14 yrs 4 mo | Serbia Molecules Private Limited |
| Pankaj Arora DIN 05298691 | Director | 25 Jun 2012 | 14 yrs 4 mo | Serbia Molecules Private Limited |
| Sachin Ahuja DIN 05298702 | Director | 25 Jun 2012 | 14 yrs 4 mo | Serbia Molecules Private Limited |
| Dinesh Wadhwa DIN 05298697 | Director | 25 Jun 2012 | 14 yrs 4 mo | Serbia Molecules Private Limited |
Financials of Serbia Molecules
Figures of Serbia Molecules Private Limited, the primary company behind Serbia Molecules, for FY 2025. Revenue was ₹50.8 Lakh (-74% year on year). Net loss was -₹53,124 (-1% margin). EBITDA was ₹1.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of -36% over three years and -24% over five years.
- ₹50.8 LakhRevenue · FY 2025 · -74% YoY
- -₹53,124Net loss · -1% margin
- ₹1.2 LakhEBITDA · 2% margin
- ₹10 LakhPaid-up capital
- -36%Revenue CAGR, 3 years
- -24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Serbia Molecules Private Limited are on its company page.
Detailed financial statements for Serbia Molecules
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Serbia Molecules
Serbia Molecules has 3 listed competitors in our database, 2 of them funded. They include Sayre Therapeutics, Ethosh and An Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sayretherapeutics.com | 2015 | Bengaluru, India | $7.9M | 23 | Access to therapies for rare and life-threatening diseases is provided. | |
| ethosh.com | 2012 | Pune, India | $275,084 | 45 | Provider of digital experience and marketing services to health-tech and life-sciences organizations | |
| anpharmaceuticals.com | 2001 | Delhi, India | 71 | A pharmaceutical marketing company with a network in Delhi-NCR and UP. |
Detailed competitors of Serbia Molecules
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Serbia Molecules
Serbia Molecules was founded in 2012.
Serbia Molecules is headquartered in Karnal, India. It is registered at Karnal, Haryana, India.
The primary company behind Serbia Molecules, Serbia Molecules Private Limited, reported revenue of ₹50.8 Lakh for FY 2025, down 74% year on year.
Serbia Molecules operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, marketing and distribution, and product formulations. A pharmaceutical marketing and PCD company offering products to distributors and franchise partners. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Serbia Molecules's top competitors include Sayre Therapeutics, Ethosh and An Pharma.
Serbia Molecules operates through Serbia Molecules Private Limited.
The legal entities of Serbia Molecules currently have 4 directors, including Anil Kumar, Pankaj Arora, Sachin Ahuja and others.